Nature Medicine
3, 1078 - 1079 (1997)
doi:10.1038/nm1097-1078
A coat of many complementsYona Zaffran
& Jerrold J. EllnerDepartment of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, USA A novel mechanism used by pathogenic mycobacteria to enter macrophages (in low complement environments) may provide a new therapeutic target for the treatment of tuberculosis.
REFERENCES
- Schlesinger, L.S. & Horwitz, M.A. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11 b/CDI 8), and CR4 (CD11C/CD18) and IFN-
 activation inhibits complement receptor function and phagocytosis of this bacterium. J. Immunol. 147, 1983−1994 (1991). | PubMed | ISI | ChemPort |
- Schorey, J.S., Carroll, M.C. & Brown, E.J. A macrophage invasion mechanism of pathogenic mycobacteria. Science 277, 1091−1093 (1997). | Article | PubMed | ISI | ChemPort |
- Cole, F.S., Mattews, W.J., Marino, J.T., Gash, D.J. & Colten, H.R. Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages. J. Immunol. 125, 1120−1124 (1980). | PubMed | ISI | ChemPort |
- Sai-Baba, K.S., Moudgil, K.D., Jain, R.C. & Srivastava, L.M. Complement activation in pulmonary tuberculosis. Tubercle 71, 103−107 (1990). | Article | PubMed | ChemPort |
- Schlesinger, L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150, 2920−2930 (1993). | PubMed | ISI | ChemPort |
- Gaynor, C.D., McCormack, F.X., Voelker, D.R., McGowan, S.E. & Schlesinger, L.S. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobecterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155, 5343−5351 (1995). | PubMed | ISI | ChemPort |
- Downing, J.F., Pasula, R., Wright, J.R., Twigg, H.L. & Martin, W.J. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 92, 4848−4852 (1995). | PubMed | ChemPort |
- Cywes, C. et al. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect. Immun. 64, 537−35383 (1996).
- Arruda, S., Bomfim, G., Knights, R., Huima-Byron, T. & Riley, L.W. Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Science 261, 1454−1457 (1993). | PubMed | ISI | ChemPort |
- Menozzi, F.D. et al. Identification of a heparin binding hemagglutinin present in mycobacteria. J. Exp. Med. 184, 993−1001 (1996). | PubMed | ISI | ChemPort |
- Shiratsuchi, H.Johnson, J.L. & Ellner, J.J. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J. Immunol. 146, 3165−3170 (1991). | PubMed | ISI | ChemPort |
- Dahl, K.E., Shiratsuchi, H., Hamilton, B.D. & Toossi, Z. Selective induction of transforming growth factor
 in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun. 64, 399−405 (1996). | PubMed | ISI | ChemPort |
- Aung, H. et al. Induction of monocyte expression of tumor necrosis factor
 by the 30 kDa antigen of Mycobacterium tuberculosis and synergism with fibronectin. J. Clin. Invest. 98, 1261−1268 (1996). | PubMed | ISI | ChemPort |
- Hirsch, C.S. et al. Cross-modulation by transforming growth factor in human tuberculosis: suppression of antigen-driven blastogenesis and interferon g production. Proc. Natl. Acad. Sci. USA 93, 3193−3198 (1996). | Article | PubMed | ChemPort |
|
